A haul of suspected counterfeit sex drugs worth an estimated £140,000 has been found in police raids. Around 28,000 suspected counterfeit erectile dysfunction tablets were seized by the Medicines and Healthcare products Regulatory Agency (MHRA) enforcement team following co-ordinated raids at three homes. The raids took place as part of Operation Fitzroy, with the assistance of Leicestershire Police, at homes in Albert Street and Moor Lane in Loughborough, along with the Metropolitan Police in Frazier Street, south east London.

Drugs that improve connections between nerve cells in the brain may be able to improve people's memory and help understand disorders such as Alzheimer's disease, scientists have revealed. A new study, published in the journal PLoS Biology, found that when a protein used to strengthen synapses in the brain was given to rats, it improved their ability to learn and retain information

The Food and Drug Administration, along with private manufacturers, announced efforts on Tuesday that they say will stave off shortages for two cancer drugs. The FDA sped up approval of a new formulation of methotrexate, a drug used to treat children’s cancer, made by  APP Pharmaceutical. It said another company that makes the drug, Hospira, had pushed out extra doses to address the ongoing shortage.

TRENTON, N.J. — Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments

VANCOUVER – A class of drugs being investigated to treat Alzheimer's disease may actually have the opposite effect of the original intent — they may impair memory, a new study in animals suggests. The drugs, known as BACE1 inhibitors, are designed to prevent the formation of the protein plaques in the brain that are a hallmark of Alzheimer's disease.

The FDA is importing two drugs, including Doxil, to ease a shortage of these critical treatments. (Ricardo DeAratanha/Los Angeles Times) Reuters 9:30 a.m. CST, February 21, 2012 The Food and Drug Administration is addressing the U.S

DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/324666/targeted_cancer_dr) has announced the addition of the “Targeted Cancer Drugs The Launch Landscape to 2018″ report to their offering. As the cancer therapy market evolves, interest is growing in novel approaches which may supersede the current portfolio

(Reuters) – The Food and Drug Administration plans to address a potentially life-threatening shortage of two leading cancer drugs by allowing one of them to be imported from abroad and rushing approval for a new manufacturer to make the second. The move announced on Tuesday is the latest government effort to stem the shortages of drugs in the United States, which doctors and patient advocates say have forced providers to postpone care or use second-best or costlier alternatives. The FDA will allow imports of a version of the cancer drug Doxil, which, in the next few weeks, should meet patient needs, the agency said

It's personal now: Alexis Borisy (left) and Michael Pellini lead an effort to make DNA data available to help cancer patients. Credit: Christopher Harting Michael Pellini fires up his computer and opens a report on a patient with a tumor of the salivary gland. The patient had surgery, but the cancer recurred

TUESDAY, Feb. 21 (HealthDay News) — The U.S. Food and Drug Administration announced Tuesday what it called a series of steps to ensure the continued availability of vital cancer drugs that have been in dangerously short supply